Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.

Detalles Bibliográficos
Autores principales: Brezina, Jan, Hlavaty, Mojmir, Bajer, Lukas, Wohl, Pavel, Spicak, Julius, Drastich, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
AGA Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212706/
http://dx.doi.org/10.1016/S0016-5085(22)61419-7
_version_ 1784730665725460480
author Brezina, Jan
Hlavaty, Mojmir
Bajer, Lukas
Wohl, Pavel
Spicak, Julius
Drastich, Pavel
author_facet Brezina, Jan
Hlavaty, Mojmir
Bajer, Lukas
Wohl, Pavel
Spicak, Julius
Drastich, Pavel
author_sort Brezina, Jan
collection PubMed
description
format Online
Article
Text
id pubmed-9212706
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92127062022-06-22 Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS. Brezina, Jan Hlavaty, Mojmir Bajer, Lukas Wohl, Pavel Spicak, Julius Drastich, Pavel Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212706/ http://dx.doi.org/10.1016/S0016-5085(22)61419-7 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Brezina, Jan
Hlavaty, Mojmir
Bajer, Lukas
Wohl, Pavel
Spicak, Julius
Drastich, Pavel
Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
title Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
title_full Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
title_fullStr Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
title_full_unstemmed Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
title_short Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
title_sort su1497: effect of sars cov-2 vaccine in ibd patients on biologic therapy including liver transplant recipients.
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212706/
http://dx.doi.org/10.1016/S0016-5085(22)61419-7
work_keys_str_mv AT brezinajan su1497effectofsarscov2vaccineinibdpatientsonbiologictherapyincludinglivertransplantrecipients
AT hlavatymojmir su1497effectofsarscov2vaccineinibdpatientsonbiologictherapyincludinglivertransplantrecipients
AT bajerlukas su1497effectofsarscov2vaccineinibdpatientsonbiologictherapyincludinglivertransplantrecipients
AT wohlpavel su1497effectofsarscov2vaccineinibdpatientsonbiologictherapyincludinglivertransplantrecipients
AT spicakjulius su1497effectofsarscov2vaccineinibdpatientsonbiologictherapyincludinglivertransplantrecipients
AT drastichpavel su1497effectofsarscov2vaccineinibdpatientsonbiologictherapyincludinglivertransplantrecipients

Ejemplares similares